These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27214822)

  • 1. Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systems.
    Kubanik M; Kandioller W; Kim K; Anderson RF; Klapproth E; Jakupec MA; Roller A; Söhnel T; Keppler BK; Hartinger CG
    Dalton Trans; 2016 Aug; 45(33):13091-103. PubMed ID: 27214822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands.
    Brissos RF; Clavero P; Gallen A; Grabulosa A; Barrios LA; Caballero AB; Korrodi-Gregório L; Pérez-Tomás R; Muller G; Soto-Cerrato V; Gamez P
    Inorg Chem; 2018 Dec; 57(23):14786-14797. PubMed ID: 30444630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes.
    Clavel CM; Păunescu E; Nowak-Sliwinska P; Griffioen AW; Scopelliti R; Dyson PJ
    J Med Chem; 2015 Apr; 58(8):3356-65. PubMed ID: 25812075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure-activity relationships and stability studies on Ru(II)(arene) anticancer complexes with biologically active ligands.
    Kurzwernhart A; Kandioller W; Enyedy ÉA; Novak M; Jakupec MA; Keppler BK; Hartinger CG
    Dalton Trans; 2013 May; 42(17):6193-202. PubMed ID: 23168616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes.
    Biancalana L; Batchelor LK; Funaioli T; Zacchini S; Bortoluzzi M; Pampaloni G; Dyson PJ; Marchetti F
    Inorg Chem; 2018 Jun; 57(11):6669-6685. PubMed ID: 29790340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution equilibria of anticancer ruthenium(II)-(η(6)-p-cymene)-hydroxy(thio)pyr(id)one complexes: impact of sulfur vs. oxygen donor systems on the speciation and bioactivity.
    Enyedy EA; Sija E; Jakusch T; Hartinger CG; Kandioller W; Keppler BK; Kiss T
    J Inorg Biochem; 2013 Oct; 127():161-8. PubMed ID: 23721887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative solution equilibrium studies of antitumor ruthenium(η
    Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
    Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
    Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
    J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Assembly of Discrete Ru
    Ajibola Adeyemo A; Shettar A; Bhat IA; Kondaiah P; Mukherjee PS
    Inorg Chem; 2017 Jan; 56(1):608-617. PubMed ID: 27997153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
    Meier SM; Novak M; Kandioller W; Jakupec MA; Arion VB; Metzler-Nolte N; Keppler BK; Hartinger CG
    Chemistry; 2013 Jul; 19(28):9297-307. PubMed ID: 23712572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ru
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.
    Ludwig G; Kaluđerović GN; Rüffer T; Bette M; Korb M; Block M; Paschke R; Lang H; Steinborn D
    Dalton Trans; 2013 Mar; 42(11):3771-4. PubMed ID: 23340605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of
    Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
    Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tridentate 3-Substituted Naphthoquinone Ruthenium Arene Complexes: Synthesis, Characterization, Aqueous Behavior, and Theoretical and Biological Studies.
    Geisler H; Westermayr J; Cseh K; Wenisch D; Fuchs V; Harringer S; Plutzar S; Gajic N; Hejl M; Jakupec MA; Marquetand P; Kandioller W
    Inorg Chem; 2021 Jul; 60(13):9805-9819. PubMed ID: 34115482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand.
    Busto N; Valladolid J; Martínez-Alonso M; Lozano HJ; Jalón FA; Manzano BR; Rodríguez AM; Carrión MC; Biver T; Leal JM; Espino G; García B
    Inorg Chem; 2013 Sep; 52(17):9962-74. PubMed ID: 23957818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [(η(6)-p-cymene)Ru(H2O)3](2+) binding capability of aminohydroxamates - A solution and solid state study.
    Parajdi-Losonczi PL; Bényei AC; Kováts É; Timári I; Muchova TR; Novohradsky V; Kasparkova J; Buglyó P
    J Inorg Biochem; 2016 Jul; 160():236-45. PubMed ID: 26971623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.
    Bhattacharyya S; Purkait K; Mukherjee A
    Dalton Trans; 2017 Jul; 46(26):8539-8554. PubMed ID: 28638907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related Ru(II)-p-cymene complexes.
    Purkait K; Chatterjee S; Karmakar S; Mukherjee A
    Dalton Trans; 2016 May; 45(20):8541-55. PubMed ID: 27120485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.